All Articles

CEO Oliver Graham heads to a key conference. With strong profits but soft volumes, Ardagh Metal Packaging must prove its strategy in a shifting global market.

Ottawa's record sport investment isn't just about soccer; it's a diversified portfolio play. We analyze the capital allocation and expected returns.

A landmark Canada-South Korea deal for LNG, crude, and critical minerals offers a new blueprint for de-risking supply chains and creates major opportunities for investors.

A Florida firm's record mulch deliveries are more than just good news; they're a data-backed blueprint for the future of sustainable materials.

With a fresh $31M, Advanced NanoTherapies is advancing a first-of-its-kind dual-drug nanoparticle balloon, a technology poised to disrupt the market.

A struggling electric vehicle maker is ditching trucks for a massive Texas power plant to fuel AI. Is it a visionary pivot or a desperate rebrand?

Conning's latest report reveals a dramatic shift in U.S. state economies. While the outlook is stable, new metrics on cost and climate are separating the winners from the losers.

A biometric breakthrough promises to solve crimes faster than ever. But as AI closes cold cases, it opens a Pandora's box of ethical and privacy questions.

Industrial AI leader Seeq is moving beyond mere analytics. At Conneqt 2026, it unveiled a vision to codify expertise into a new corporate asset class.

A new partnership between Volpi Foods and Blaze Pizza signals a major shift, as ethical sourcing and artisanal quality become key drivers in fast-casual dining.

The $320B tokenized asset market is notoriously illiquid. Symbiotic's Liquid Lane aims to change that with a novel shared collateral model for instant redemptions.

Beyond the headlines of EHA 2026, Eli Lilly's latest data and acquisitions reveal a bold strategy to conquer the hematology market. It's a three-pronged assault.

Volition America's Jeep giveaway for military heroes is more than a contest; it's a masterclass in modern brand-building and corporate philanthropy.

As the Pentagon plans a 200,000-drone fleet, one small firm is making a big play. Mobilicom's pitch to top investors reveals a critical new frontline: cybersecurity.

Quoin Pharmaceuticals files the first-ever drug application for Peeling Skin Syndrome, offering a glimmer of hope for patients with no treatment options.

An Israeli-American tech firm just put AI eyes on a US Black Hawk, pioneering a new era of visual predictive maintenance that could transform aviation safety.

A strategic investment in AxisCare signals a major shift as private equity fuels AI's move from the data center to the living room, reshaping elder care.

As AI's power demand soars, a Canadian firm has confirmed a massive natural hydrogen system, promising a cheap, clean fuel source directly from the earth.

As one major allergy drug exits, a biotech startup is testing a new path: a microneedle skin stamp. Is this the future of allergy treatment?

With a key promotion and hires specializing in digital assets and niche liquidity, Wedbush is betting on talent and tech to win the future of equity trading.